Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Russell

Showing results (1301-1310 of 1,332) with videos related to

Pageof 134
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 28, 2021
Binding characteristics of [<sup>18</sup>F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PETMengmeng Song, Leonie Beyer, Lena Kaiser, et al.
Science (New York, N.Y.)|September 22, 2007
A closer look at water-related geologic activity on MarsA S McEwen, C J Hansen, W A Delamere, et al.
Clinical Rheumatology|March 28, 2019
PANLAR consensus statement on biosimilarsS C Kowalski, J A Benavides, P A B Roa, et al.
Clinical Rheumatology|May 22, 2019
Correction to: PANLAR consensus statement on biosimilarsS C Kowalski, J A Benavides, P A Beltrán, et al.
Blood|December 22, 2018
Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphomaAnnemieke W J Opstal-van Winden, Hugoline G de Haan, Michael Hauptmann, et al.
Plos One|January 4, 2023
A large-scale genetic screen identifies genes essential for motility in Agrobacterium fabrumDiana G Calvopina-Chavez, Robyn E Howarth, Audrey K Memmott, et al.
The New England Journal of Medicine|August 3, 2022
Trial of Prasinezumab in Early-Stage Parkinson's DiseaseGennaro Pagano, Kirsten I Taylor, Judith Anzures-Cabrera, et al.
The New England Journal of Medicine|November 5, 2025
Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast CancerIan H Kunkler, Nicola S Russell, Niall Anderson, et al.
NPJ Breast Cancer|September 9, 2023
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trialSonja Vliek, Florentine S Hilbers, Erik van Werkhoven, et al.
Nature Medicine|May 16, 2019
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialLeonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Pageof 134

Showing results (1301-1310 of 1,332) with videos related to

Sort By:
Pageof 134
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 28, 2021
Binding characteristics of [<sup>18</sup>F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PETMengmeng Song, Leonie Beyer, Lena Kaiser, et al.
Science (New York, N.Y.)|September 22, 2007
A closer look at water-related geologic activity on MarsA S McEwen, C J Hansen, W A Delamere, et al.
Clinical Rheumatology|March 28, 2019
PANLAR consensus statement on biosimilarsS C Kowalski, J A Benavides, P A B Roa, et al.
Clinical Rheumatology|May 22, 2019
Correction to: PANLAR consensus statement on biosimilarsS C Kowalski, J A Benavides, P A Beltrán, et al.
Blood|December 22, 2018
Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphomaAnnemieke W J Opstal-van Winden, Hugoline G de Haan, Michael Hauptmann, et al.
Plos One|January 4, 2023
A large-scale genetic screen identifies genes essential for motility in Agrobacterium fabrumDiana G Calvopina-Chavez, Robyn E Howarth, Audrey K Memmott, et al.
The New England Journal of Medicine|August 3, 2022
Trial of Prasinezumab in Early-Stage Parkinson's DiseaseGennaro Pagano, Kirsten I Taylor, Judith Anzures-Cabrera, et al.
The New England Journal of Medicine|November 5, 2025
Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast CancerIan H Kunkler, Nicola S Russell, Niall Anderson, et al.
NPJ Breast Cancer|September 9, 2023
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trialSonja Vliek, Florentine S Hilbers, Erik van Werkhoven, et al.
Nature Medicine|May 16, 2019
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialLeonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Pageof 134